BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 33758861)

  • 21. Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco.
    Peng J; Liu J; Mann SA; Mitchell AM; Laurie MT; Sunshine S; Pilarowski G; Ayscue P; Kistler A; Vanaerschot M; Li LM; McGeever A; Chow ED; Marquez C; Nakamura R; Rubio L; Chamie G; Jones D; Jacobo J; Rojas S; Rojas S; Tulier-Laiwa V; Black D; Martinez J; Naso J; Schwab J; Petersen M; Havlir D; DeRisi J;
    Clin Infect Dis; 2022 Jan; 74(1):32-39. PubMed ID: 33788923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid screening assay for L452R and T478K spike mutations in SARS-CoV-2 Delta variant using high-resolution melting analysis.
    Aoki A; Adachi H; Mori Y; Ito M; Sato K; Okuda K; Sakakibara T; Okamoto Y; Jinno H
    J Toxicol Sci; 2021; 46(10):471-476. PubMed ID: 34602531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Computational Approach to Evaluate the Combined Effect of SARS-CoV-2 RBD Mutations and ACE2 Receptor Genetic Variants on Infectivity: The COVID-19 Host-Pathogen Nexus.
    Ashoor D; Ben Khalaf N; Marzouq M; Jarjanazi H; Chlif S; Fathallah MD
    Front Cell Infect Microbiol; 2021; 11():707194. PubMed ID: 34434902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutant receptor-binding domain with ACE2.
    Dash P; Turuk J; Behera SK; Palo SK; Raghav SK; Ghosh A; Sabat J; Rath S; Subhadra S; Rana K; Bhattacharya D; Kanungo S; Kshatri JS; Mishra BK; Dash S; Parida A; Pati S
    Int J Infect Dis; 2021 Mar; 104():491-500. PubMed ID: 33450373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Double Mutation (L452R and E484Q) on the Binding Affinity of Monoclonal Antibodies (mAbs) against the RBD-A Target for Vaccine Development.
    Gupta D; Kumar M; Sharma P; Mohan T; Prakash A; Kumari R; Kaur P
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution and Functional Analyses of Mutations in Spike Protein and Phylogenic Diversity of SARS-CoV-2 Variants Emerged during the Year 2021 in India.
    Gopalan V; Chandran A; Arumugam K; Sundaram M; Velladurai S; Govindan K; Azhagesan N; Jeyavel P; Dhandapani P; Sivasubramanian S; Kitambi SS
    J Glob Infect Dis; 2023; 15(2):43-51. PubMed ID: 37469462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein.
    Liu J; Chen X; Liu Y; Lin J; Shen J; Zhang H; Yin J; Pu R; Ding Y; Cao G
    Infect Dis Poverty; 2021 Aug; 10(1):112. PubMed ID: 34419160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677.
    Hodcroft EB; Domman DB; Snyder DJ; Oguntuyo KY; Van Diest M; Densmore KH; Schwalm KC; Femling J; Carroll JL; Scott RS; Whyte MM; Edwards MW; Hull NC; Kevil CG; Vanchiere JA; Lee B; Dinwiddie DL; Cooper VS; Kamil JP
    medRxiv; 2021 Feb; ():. PubMed ID: 33594385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of Novel SARS-CoV-2 variants in India: second wave.
    Adiga R; Nayak V
    J Infect Dev Ctries; 2021 Nov; 15(11):1578-1583. PubMed ID: 34898481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations of SARS-CoV-2 RBD May Alter Its Molecular Structure to Improve Its Infection Efficiency.
    Alaofi AL; Shahid M
    Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging Vaccine-Breakthrough SARS-CoV-2 Variants.
    Wang R; Chen J; Hozumi Y; Yin C; Wei GW
    ACS Infect Dis; 2022 Mar; 8(3):546-556. PubMed ID: 35133792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the B.1.1.7 SARS-CoV-2 Spike Protein Reduce Receptor-Binding Affinity and Induce a Flexible Link to the Fusion Peptide.
    Socher E; Conrad M; Heger L; Paulsen F; Sticht H; Zunke F; Arnold P
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34066729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phylodynamic Pattern of Genetic Clusters, Paradigm Shift on Spatio-Temporal Distribution of Clades, and Impact of Spike Glycoprotein Mutations of SARS-CoV-2 Isolates from India.
    Sivasubramanian S; Gopalan V; Ramesh K; Padmanabhan P; Mone K; Govindan K; Velladurai S; Dhandapani P; Krishnasamy K; Kitambi SS
    J Glob Infect Dis; 2021; 13(4):164-171. PubMed ID: 35017872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity.
    Li Q; Wu J; Nie J; Zhang L; Hao H; Liu S; Zhao C; Zhang Q; Liu H; Nie L; Qin H; Wang M; Lu Q; Li X; Sun Q; Liu J; Zhang L; Li X; Huang W; Wang Y
    Cell; 2020 Sep; 182(5):1284-1294.e9. PubMed ID: 32730807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging vaccine-breakthrough SARS-CoV-2 variants.
    Wang R; Chen J; Hozumi Y; Yin C; Wei GW
    ArXiv; 2021 Sep; ():. PubMed ID: 34518803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
    Qiao B; Olvera de la Cruz M
    ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity.
    Raghav S; Ghosh A; Turuk J; Kumar S; Jha A; Madhulika S; Priyadarshini M; Biswas VK; Shyamli PS; Singh B; Singh N; Singh D; Datey A; Avula K; Smita S; Sabat J; Bhattacharya D; Kshatri JS; Vasudevan D; Suryawanshi A; Dash R; Senapati S; Beuria TK; Swain R; Chattopadhyay S; Syed GH; Dixit A; Prasad P; ; ; Pati S; Parida A
    Front Microbiol; 2020; 11():594928. PubMed ID: 33329480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid Increase of SARS-CoV-2 Variant B.1.1.7 Detected in Sewage Samples from England between October 2020 and January 2021.
    Wilton T; Bujaki E; Klapsa D; Majumdar M; Zambon M; Fritzsche M; Mate R; Martin J
    mSystems; 2021 Jun; 6(3):e0035321. PubMed ID: 34128696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 Delta Variant is Recognized Through GRP78 Host-Cell Surface Receptor, In Silico Perspective.
    Elfiky AA; Ibrahim IM; Elgohary AM
    Int J Pept Res Ther; 2022; 28(5):146. PubMed ID: 36034049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.